Google is developing a collection of 'open' AI models for drug discovery called TxGemma.The AI models can understand both 'regular text' and the structures of 'therapeutic entities' like chemicals, molecules, and proteins.Researchers can use TxGemma to predict important properties of potential therapies, such as safety and effectiveness.While AI has shown promise in drug discovery, there have been some failures and the accuracy of AI systems can vary widely.